Curist Lidocaine Patch

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Curist Lidocaine Patch
Generic name: LIDOCAINE 4% PATCH
Manufacturer: Little Pharma, Inc.
Product type: HUMAN OTC DRUG
SPL set ID: 1a8fe44e-7a21-c2ab-e063-6394a90a6100
SPL ID: 4821e735-be15-0d6e-e063-6394a90a0100
Version: 4
Effective date: 2026-01-11
Source export date: 2026-11-06
Source partition: 7
Source file: https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-11-06/824fe785252d7061429a95ddb6de517ee399ef628d34e8fdcc3591ded286ae33/drug-label-0007-of-0014.json.zip
Source manifest SHA-256: 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run: 20261108T063105Z
Imported at: 2026-11-08 07:25:30

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Curist Lidocaine Patch	openfda.brand_name
generic name		LIDOCAINE 4% PATCH	openfda.generic_name
manufacturer name		Little Pharma, Inc.	openfda.manufacturer_name
ndc	package	72559-026-19	openfda.package_ndc
ndc	product	72559-026	openfda.product_ndc
ndc11	package	72559002619	derived:openfda.package_ndc
rxcui		1737778	openfda.rxcui
spl id		4821e735-be15-0d6e-e063-6394a90a0100	id
spl set id		1a8fe44e-7a21-c2ab-e063-6394a90a6100	set_id
unii		98PI200987	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Do not use on raw surfaces, blistered areas, wounds or other damaged skin with a heating pad more than one patch on your body at a time with other topical analgesics When using this product use only as directed avoid contact with the eyes do not bandage tightly Stop use and ask a doctor if pain, swelling, blistering or other irritation occurs where patch was applied condition worsens symptoms persist for more than 7 days, or clear up and occur again within a few days If pregnant or breast-feeding, ask a health professional before use.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.